Abstract-Posttranscriptional regulation of endothelial nitric oxide synthase (eNOS) expression is an important mechanism by which endothelial cells respond to various physiological and pathophysiological stimuli. Previously, we showed that eNOS expression was dramatically altered by the state of cell growth and that the mechanism responsible for this regulation was entirely posttranscriptional, occurring via changes in eNOS mRNA stability. The present study identifies a role for actin cytoskeleton organization in the posttranscriptional regulation of eNOS during cell growth and examines the relationship between the state of actin polymerization and eNOS expression. We identified monomeric actin (globular [G]-actin) as the major component of a 51-kDa ribonucleoprotein that binds to the eNOS mRNA 3Ј untranslated region in UV-crosslinking analysis. Binding activity of the ribonucleoprotein complex correlated with the relative concentration of G-actin versus filamentous actin (F-actin). ENOS transcripts colocalized with cytoplasmic G-actin in cells subjected to fluorescence in situ hybridization and G-actin fluorescence staining. In subcellular fractionation studies, eNOS transcripts were enriched in the free polysomal fraction of nonproliferating cells and enriched in the cell matrix-associated polysomal fraction of proliferating cells. Furthermore, an inverse relationship between the concentration of G-actin and eNOS expression was observed in endothelial cells subjected to pharmacological alteration of their cytoskeleton; lower G/F-actin ratios correlated with increased eNOS expression. Our findings provide some insight into how endothelial cells may use the dynamic organization of the actin cytoskeleton to regulate expression of an enzyme that is crucial to vascular homeostasis. Key Words: endothelial nitric oxide synthase Ⅲ mRNA binding protein Ⅲ mRNA stability Ⅲ 3Ј untranslated region Ⅲ cytoskeletal dynamics N itric oxide (NO⅐) is produced in vascular endothelial cells by the endothelial isoform of nitric oxide synthase (eNOS). 1 NO⅐ is crucial to the maintenance of vascular homeostasis through its vasodilator activity, 1 and its ability to inhibit smooth muscle growth, 2 platelet aggregation, 3 and leukocyte adhesion. 4 Although eNOS is constitutively expressed, several biophysical and biochemical stimuli that have been implicated in vascular pathophysiology can modify the expression of eNOS. In cultured cells, shear stress, 5 lysophosphatidylcholine, 6 low concentrations of oxidized low-density lipoprotein, 7 oxidized linoleic acid, 8 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, 9 and hydrogen peroxide 10 increased eNOS expression. In contrast, exposure of cultured cells to tumor necrosis factor-␣, 11 hypoxia, 12 lipopolysaccaride, 13 thrombin, 14 and high concentrations of oxidized low-density lipoprotein 15 all decreased eNOS levels. For many of these stimuli, modulation of eNOS mRNA stability plays an essential role in determining eNOS expression. However, the details of the mechanism(s) re...